Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

F0005000

Famotidine

European Pharmacopoeia (EP) Reference Standard

Sinônimo(s):

Famotidine, N′-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C8H15N7O2S3
Número CAS:
76824-35-6
Peso molecular:
337.45
Número MDL:
MFCD00079297
Código UNSPSC:
41116107
ID de substância PubChem:
329799617
NACRES:
NA.24

fonte biológica

synthetic

grau

pharmaceutical primary standard

Agency

EP Reference Standard

família API

famotidine

Formulário

solid

embalagem

pkg of 110 mg

fabricante/nome comercial

EDQM

condição de armazenamento

protect from light

aplicação(ões)

pharmaceutical (small molecule)

Formato

neat

Condições de expedição

ambient

temperatura de armazenamento

2-8°C

cadeia de caracteres SMILES

N\C(N)=N\c1nc(CSCCC(=N)NS(N)(=O)=O)cs1

InChI

1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)

chave InChI

XUFQPHANEAPEMJ-UHFFFAOYSA-N

Informações sobre genes

human ... HRH2(3274)

Procurando produtos similares? Visita Guia de comparação de produtos

Categorias relacionadas

Descrição geral

Famotidine is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.

Ações bioquímicas/fisiológicas

H2 histamine receptor antagonist; anti-ulcer agent

Embalagem

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Outras notas

Sales restrictions may apply.

produto relacionado

Nº do produto
Descrição
Preços

PHR1055

Famotidine, Pharmaceutical Secondary Standard; Certified Reference Material

Y0000409

Famotidine impurity D, European Pharmacopoeia (EP) Reference Standard

Y0000382

Famotidine for system suitability, European Pharmacopoeia (EP) Reference Standard

1269200

Famotidine, United States Pharmacopeia (USP) Reference Standard

1269243

Famotidine Related Compound D, United States Pharmacopeia (USP) Reference Standard

1269265

Famotidine Related Compound F, United States Pharmacopeia (USP) Reference Standard

1269221

Famotidine Related Compound B, United States Pharmacopeia (USP) Reference Standard

1269232

Famotidine Related Compound C, United States Pharmacopeia (USP) Reference Standard

1269254

Famotidine Related Compound E, United States Pharmacopeia (USP) Reference Standard

BP653

Famotidine, British Pharmacopoeia (BP) Reference Standard

PHR2908

Famotidine Related Compound F, certified reference material, pharmaceutical secondary standard

PHR2909

Famotidine Related Compound B, certified reference material, pharmaceutical secondary standard

PHR2910

Famotidine Related Compound C

PHR2911

Famotidine Related Compound D

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 2

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

H Echizen et al.
Clinical pharmacokinetics, 21(3), 178-194 (1991-09-01)
Famotidine is a potent histamine H2-receptor antagonist widely used in the treatment and prevention of peptic ulcer disease. After intravenous administration the plasma famotidine concentration-time profile exhibits a biexponential decay, with a distribution half-life of about 0.18 to 0.5h and
M C Martinez
The Annals of pharmacotherapy, 33(6), 742-747 (1999-07-20)
To evaluate the use and potential benefit of famotidine in the management of schizophrenia. Clinical literature accessed through MEDLINE (February 1998-October 1998). Key search terms included famotidine, schizophrenia, and histamine. Schizophrenia is a complicated disorder associated with high morbidity if
A N Chremos
Journal of clinical gastroenterology, 9 Suppl 2, 7-12 (1987-01-01)
Famotidine is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect in humans is inhibition of gastric acid secretion. Dose-related suppression of basal and stimulated (meal, pentagastrin) gastric acid output has been shown with oral doses of 5-40 mg. The
C W Howden et al.
Clinical therapeutics, 18(1), 36-54 (1996-01-01)
Famotidine is a specific, long-acting histamine2-receptor antagonist. It is indicated for the treatment of duodenal ulcer, gastric ulcer, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. Since its introduction for the treatment of acid-related disorders in 1985, an estimated 18.8 million patients
[Famotidine--a new histamine H2 receptor blockader].
P Ia Grigor'ev et al.
Klinicheskaia meditsina, 69(4), 23-28 (1991-04-01)
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica